Various cellular protective mechanisms along the DNA-cGAS-cGAMP-STING pathway have been explored as potential therapeutic targets, in addition to STING agonists.138 Upstream, enhancing DNA levels by inhibiting the degradative activity of extracellular nucleases like TREX1 has been shown to improve tumor control by radiotherapy. Here, STING1 is linked to neoplasm.